Policy & Regulation

Methodological Description

Using a national Medicaid database, the report shows significant racial/ethnic disparities in mental health service use among children during the COVID-19 pandemic.

In recent years several researchers and child welfare agencies have begun developing predictive risk models to support child welfare decision-making. Predictive analytics is a sophisticated form of risk modeling that uses historical data to understand relationships between myriad factors to estimate a probability score for the outcome of interest.

This Data Point presents changes in HealthCare.gov enrollment by race and ethnicity from 2015-2022 using a validated imputation method for missing information on race and ethnicity.

This study updates ASPE’s previous analysis of the associations between COVID-19 hospitalizations and deaths among Medicare beneficiaries and COVID-19 vaccination rates, with full year data through the end of 2021.

The Department of Health and Human Services (HHS) has several different policy groups such as the HHS Data Council, Data Governance Board, Evidence and Evaluation Policy Council, and the HHS AI Council that frequently use many terms related to data, but likely with inconsistent understanding of their definitions and how these terms should be used.

The U.S. Department of Health and Human Services (HHS) enhances the health and well-being of all Americans by advancing equity, addressing social determinants of health, and supporting underserved communities.

High prescription drug costs are a leading concern among Americans. Americans pay higher prices for prescription drugs than any other country in the world, with prescription drug prices in the U.S. more than 2.5 times as high as those in other similar high-income nations.

Prescription drug price increases create affordability challenges for patients and for the government. This report tracks drug price changes from 2016-2022. There were 1,216 products whose price increases during the twelve-month period from July 2021 to July 2022 exceeded the inflation rate of 8.5 percent for that time period. The average price increase for these drugs was 31.6 percent.

This Brief presents information about the risk of needing care and associated costs to provide content for policymakers and others considering long-term care financing proposals. It revises a brief that was written in October 2020.